Seeking Alpha

Cerus (CERS +70%) soars after Swiss regulators approve its Intercept blood system, which...

Cerus (CERS +70%) soars after Swiss regulators approve its Intercept blood system, which lengthens platelets' shelf life by two days to a week by inactivating blood-borne pathogens. Drug is not yet available in U.S.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|